The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Open accessAbstract
DNA topoisomerases are the targets of important anticancer and antibacterial drugs. Camptothecins and novel noncamptothecins in clinical development (indenoisoquinolines and ARC-111) target eukaryotic type IB topoisomerases (Top1), whereas human type IIA topoisomerases (Top2alpha and Top2beta) are the targets of the widely used anticancer agents etoposide, anthracyclines (doxorubicin, daunorubicin), and mitoxantrone. Bacterial type II topoisomerases (gyrase and Topo IV) are the targets of quinolones and aminocoumarin antibiotics. This review focuses on the molecular and biochemical characteristics of topoisomerases and their inhibitors. We also discuss the common mechanism of action of topoisomerase poisons by interfacial inhibition and trapping of topoisomerase cleavage complexes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.
Hsiang, Y. H., Hertzberg, R., Hecht, S., & Liu, L. F. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38654-4 · Cited by 2,362
Cellular roles of DNA topoisomerases: a molecular perspective
Wang, J. C. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm831 · Cited by 2,353
Topoisomerase I inhibitors: camptothecins and beyond
Pommier, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1977 · Cited by 2,277
Self-citationWall, M. E., Wani, M. C., Cook, C. E., Palmer, K. H., McPhail, A. T., & Sim, G. A. (1966) · Journal of the American Chemical Society · doi:10.1021/ja00968a057 · Cited by 2,258
Supercoiling of the DNA template during transcription.
Liu, L. F., & Wang, J. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7024 · Cited by 1,962
Targeting DNA topoisomerase II in cancer chemotherapy
Nitiss, J. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2607 · Cited by 1,791
DNA gyrase: an enzyme that introduces superhelical turns into DNA.
Gellert, M., Mizuuchi, K., O'Dea, M. H., & Nash, H. A. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.11.3872 · Cited by 1,204
Cell cycle kinases as therapeutic targets for cancer
Lapenna, S., & Giordano, A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2907 · Cited by 905
Tewey, K. M., Chen, G. L., Nelson, E. M., & Liu, L. F. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)47282-6 · Cited by 887 · cited 1×
“Inhibition of Top2 catalytic activity without trapping cleavage complexes is also observed for DNA intercalators at drug concentrations that alter DNA structure, thereby preventing Top2 from binding DNA (step 1 in Figure 5A) or from forming Top2cc (step 3) (Pommier et al., 1984; Tewey et al., 1984).”
DNA topoisomerase II and its growing repertoire of biological functions
Nitiss, J. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2608 · Cited by 885
A Topoisomerase IIß-Mediated dsDNA Break Required for Regulated Transcription
Ju, B.-G., Lunyak, V. V., Perissi, V., Garcia-Bassets, I., Rose, D. W., Glass, C. K., & Rosenfeld, M. G. (2006) · Science · doi:10.1126/science.1127196 · Cited by 840
The mechanism of topoisomerase I poisoning by a camptothecin analog
Staker, B. L., Hjerrild, K., Feese, M. D., Behnke, C. A., Burgin, A. B., & Stewart, L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242259599 · Cited by 818
Interaction between DNA and an Escherichia coli protein ω
Wang, J. C. (1971) · Journal of Molecular Biology · doi:10.1016/0022-2836(71)90334-2 · Cited by 786
Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L. M., & Nakamura, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.8.1647 · Cited by 777
1,8-Naphthyridine Derivatives. A New Class of Chemotherapeutic Agents
Lesher, G. Y., Froelich, E. J., Gruett, M. D., Bailey, J. H., & Brundage, R. P. (1962) · Journal of Medicinal and Pharmaceutical Chemistry · doi:10.1021/jm01240a021 · Cited by 766
Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.
Gellert, M., O'Dea, M. H., Itoh, T., & Tomizawa, J. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.12.4474 · Cited by 727
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
Pommier, Y. (2009) · Chemical Reviews · doi:10.1021/cr900097c · Cited by 707
Self-citationNew topoisomerase essential for chromosome segregation in E. coli
Kato, J.-I., Nishimura, Y., Imamura, R., Niki, H., Hiraga, S., & Suzuki, H. (1990) · Cell · doi:10.1016/0092-8674(90)90172-b · Cited by 566
Tuduri, S., Crabbé, L., Conti, C., Tourrière, H., Holtgreve-Grez, H., Jauch, A., Pantesco, V., De Vos, J., Thomas, A., Theillet, C., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1984 · Cited by 550
Self-citationDNA Oxidation as Triggered by H3K9me2 Demethylation Drives Estrogen-Induced Gene Expression
Perillo, B., Ombra, M. N., Bertoni, A., Cuozzo, C., Sacchetti, S., Sasso, A., Chiariotti, L., Malorni, A., Abbondanza, C., & Avvedimento, E. V. (2008) · Science · doi:10.1126/science.1147674 · Cited by 527
DNA topoisomerases: harnessing and constraining energy to govern chromosome topology
Schoeffler, A. J., & Berger, J. M. (2008) · Quarterly Reviews of Biophysics · doi:10.1017/s003358350800468x · Cited by 490
The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing
Deweese, J. E., & Osheroff, N. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn937 · Cited by 462
Jaxel, C., Kohn, K. W., Wani, M. C., Wall, M. E., & Pommier, Y. G. (1989) · PubMed · Cited by 449
Self-citationUemura, T., & Yanagida, M. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02040.x · Cited by 448
Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
D’Arpa, P., Beardmore, C., & Liu, L. F. (1990) · PubMed · Cited by 425
Yang, S. W., Burgin, A. B., Huizenga, B. N., Robertson, C. A., Yao, K. C., & Nash, H. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11534 · Cited by 412
A human 5′-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage
Ledesma, F. C., El Khamisy, S. F., Zuma, M. C., Osborn, K., & Caldecott, K. W. (2009) · Nature · doi:10.1038/nature08444 · Cited by 408
Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia
Strick, R., Strissel, P. L., Borgers, S., Smith, S. L., & Rowley, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070061297 · Cited by 390
DNA topoisomerase I is involved in both repression and activation of transcription
Merino, A., Madden, K. R., Lane, W. S., Champoux, J. J., & Reinberg, D. (1993) · Nature · doi:10.1038/365227a0 · Cited by 385
Yeast Gene for a Tyr-DNA Phosphodiesterase that Repairs Topoisomerase I Complexes
Pouliot, J. J., Yao, K. C., Robertson, C. A., & Nash, H. A. (1999) · Science · doi:10.1126/science.286.5439.552 · Cited by 382
Ferrero, L., Cameron, B., Manse, B., Lagneaux, D., Crouzet, J., Famechon, A., & Blanche, F. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00458.x · Cited by 378
Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture.
Wall, M. E., & Wani, M. C. (1995) · PubMed · Cited by 376
Quinolones: Action and Resistance Updated
Drlica, K., Hiasa, H., Kerns, R., Malik, M., Mustaev, A., & Zhao, X. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789630947 · Cited by 376
Zwelling, L. A., Michaels, S., Erickson, L. C., Ungerleider, R. S., Nichols, M., & Kohn, K. W. (1981) · Biochemistry · doi:10.1021/bi00526a006 · Cited by 374
Topoisomerase II as a target for anticancer drugs: When enzymes stop being nice
Fortune, J. M., & Osheroff, N. (2000) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(00)64006-0 · Cited by 366
Holm, C., Covey, J. M., Kerrigan, D., & Pommier, Y. G. (1989) · PubMed · Cited by 366
Self-citationChampoux, J. J., & Dulbecco, R. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.1.143 · Cited by 346
Origin and evolution of DNA topoisomerases
Forterre, P., Gribaldo, S., Gadelle, D., & Serre, M.-C. (2007) · Biochimie · doi:10.1016/j.biochi.2006.12.009 · Cited by 343
DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues.
Hsiang, Y. H., Liu, L. F., Wall, M. E., Wani, M. C., Nicholas, A. W., Manikumar, G., Kirschenbaum, S., Silber, R., & Potmĕsil, M. (1989) · PubMed · Cited by 339
Lewis, R. J., Singh, O. M., Smith, C. V., Skarzynski, T., Maxwell, A., Wonacott, A. J., & Wigley, D. B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00483.x · Cited by 335
Camptothecin and taxol: Discovery to clinic
Wall, M. E. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199809)18:5<299::aid-med2>3.0.co;2-o · Cited by 330
Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.
Eng, W. K., Faucette, L., Johnson, R. K., & Sternglanz, R. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10121-1 · Cited by 325
Friction and torque govern the relaxation of DNA supercoils by eukaryotic topoisomerase IB
Koster, D. A., Croquette, V., Dekker, C., Shuman, S., & Dekker, N. H. (2005) · Nature · doi:10.1038/nature03395 · Cited by 324
Structural insight into the quinolone–DNA cleavage complex of type IIA topoisomerases
Laponogov, I., Sohi, M. K., Veselkov, D. A., Pan, X.-S., Sawhney, R., Thompson, A. W., McAuley, K. E., Fisher, L. M., & Sanderson, M. R. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1604 · Cited by 304
Repair of Topoisomerase I‐Mediated DNA Damage
Pommier, Y., Barcelo, J. M., Rao, V. A., Sordet, O., Jobson, A. G., Thibaut, L., Miao, Z., Seiler, J. A., Zhang, H., Marchand, C., et al. (2006) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(06)81005-6 · Cited by 291
Self-citationRoles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies
Azarova, A. M., Lyu, Y. L., Lin, C.-P., Tsai, Y.-C., Lau, J. Y.-N., Wang, J. C., & Liu, L. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704002104 · Cited by 286
Brangi, M., Litman, T., Ciotti, M., Nishiyama, K., Kohlhagen, G., Takimoto, C. H. M., Robey, R. W., Pommier, Y. G., Fojo, T., & Bates, S. E. (1999) · PubMed · Cited by 263
Self-citationGenetic pathways in therapy-related myelodysplasia and acute myeloid leukemia
Pedersen-Bjergaard, J., Andersen, M. K., Christiansen, D. H., & Nerlov, C. (2002) · Blood · doi:10.1182/blood.v99.6.1909 · Cited by 246
(1997) · PubMed · Cited by 238
Human Tdp1 Cleaves a Broad Spectrum of Substrates, Including Phosphoamide Linkages
Interthal, H., Chen, H. J., & Champoux, J. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508898200 · Cited by 221
Desai, S. D., Li, T., Rodriguez-Bauman, A., Rubin, E. H., & Liu, L. F. (2001) · PubMed · Cited by 219
DNA Gyrase and Topoisomerase IV Are Dual Targets of Clinafloxacin Action in Streptococcus pneumoniae
Pan, X.-S., & Fisher, L. M. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2810 · Cited by 215
Human mitochondrial topoisomerase I
Zhang, H., Barceló, J. M., Lee, B., Kohlhagen, G., Zimonjic, D. B., Popescu, N. C., & Pommier, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191321998 · Cited by 214
Self-citationEffect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin.
Jaxel, C., Capranico, G., Kerrigan, D., Kohn, K. W., & Pommier, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54939-5 · Cited by 202
Self-citationLong, B. H., Musial, S. T., & Brattain, M. G. (1985) · PubMed · Cited by 188
Targeted Disruption of the Mouse Topoisomerase I Gene by Camptothecin Selection
Morham, S. G., Kluckman, K. D., Voulomanos, N., & Smithies, O. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6804 · Cited by 187
Capranico, G., Kohn, K. W., & Pommier, Y. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.22.6611 · Cited by 186
Self-citationTopoisomerase I inhibitors: selectivity and cellular resistance
Pommier, Y., Pourquier, P., Urasaki, Y., Wu, J., & Laco, G. S. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0102 · Cited by 182
Self-citationNext generation topoisomerase I inhibitors: Rationale and biomarker strategies
Teicher, B. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.10.016 · Cited by 176
Human Topoisomerase IIα Rapidly Relaxes Positively Supercoiled DNA
McClendon, A. K., Rodriguez, A. C., & Osheroff, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503320200 · Cited by 176
Marchand, C., Antony, S., Kohn, K. W., Cushman, M., Ioanoviciu, A., Staker, B. L., Burgin, A. B., Stewart, L., & Pommier, Y. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0456 · Cited by 167
Self-citationKaufmann, S. H. (1991) · PubMed · Cited by 164
The indenoisoquinoline noncamptothecin topoisomerase I inhibitors: update and perspectives
Pommier, Y., & Cushman, M. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0706 · Cited by 161
Self-citationDNA Helicases Required for Homologous Recombination and Repair of Damaged Replication Forks
Wu, L., & Hickson, I. D. (2006) · Annual Review of Genetics · doi:10.1146/annurev.genet.40.110405.090636 · Cited by 158
Ratain, M. J., & Rowley, J. D. (1992) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058121 · Cited by 156
Homocamptothecins: Synthesis and Antitumor Activity of Novel E-Ring-Modified Camptothecin Analogues
Lavergne, O., Lesueur‐Ginot, L., Rodas, F. P., Kasprzyk, P. G., Pommier, J., Demarquay, D., Prevost, G. P., Ulíbarri, G., Rolland, A., Schiano, A., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980400l · Cited by 155
Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae
Pouliot, J. J., Robertson, C. A., & Nash, H. A. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00452.x · Cited by 152
Fujimori, A., Harker, W. G., Kohlhagen, G., Hoki, Y., & Pommier, Y. G. (1995) · PubMed · Cited by 151
Self-citationDebéthune, L. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.5.1198 · Cited by 147
A Protease Pathway for the Repair of Topoisomerase II-DNA Covalent Complexes
Zhang, A., Lyu, Y. L., Lin, C., Zhou, N., Azarova, A. M., Wood, L. M., & Liu, L. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604149200 · Cited by 146
Topoisomerase II and the etiology of chromosomal translocations
Felix, C. A., Kolaris, C. P., & Osheroff, N. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.05.031 · Cited by 145
Tyrosyl-DNA Phosphodiesterase as a Target for Anticancer Therapy
Dexheimer, T. S., Antony, S., Marchand, C., & Pommier, Y. G. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008784220357 · Cited by 144
Self-citationPommier, Y. G., Schwartz, R. E., Kohn, K. W., & Zwelling, L. A. (1984) · Biochemistry · doi:10.1021/bi00309a013 · Cited by 138
Self-citationMechanisms of Camptothecin Resistance by Human Topoisomerase I Mutations
Chrencik, J., Staker, B. L., Burgin, A. B., Pourquier, P., Pommier, Y. G., Stewart, L. J., & Redinbo, M. R. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.03.077 · Cited by 136
Self-citationHuman TOP3: a single-copy gene encoding DNA topoisomerase III.
Hanai, R., Caron, P. R., & Wang, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3653 · Cited by 133
DNA topology and topoisomerases
Deweese, J. E., Osheroff, M. A., & Osheroff, N. (2009) · Biochemistry and Molecular Biology Education · doi:10.1002/bmb.20244 · Cited by 129
Eng, W.-K., McCabe, F. L., Tan, K. B., et al. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09473-8 · Cited by 127
DNA sequence selectivity of topoisomerases and topoisomerase poisons
Capranico, G., & Binaschi, M. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00135-3 · Cited by 116
Nonclassic Functions of Human Topoisomerase I: Genome-Wide and Pharmacologic Analyses
Miao, Z., Player, A. N., Shankavaram, U. T., Wang, Y.-H., Zimonjic, D. B., Lorenzi, P. L., Liao, Z.-Y., Liu, H., Shimura, T., Zhang, H.-L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4554 · Cited by 113
Self-citationIoanoviciu, A., Antony, S., Pommier, Y. G., Staker, B. L., Stewart, L. J., & Cushman, M. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050076b · Cited by 111
Self-citationSirikantaramas, S., Yamazaki, M., & Saito, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801038105 · Cited by 111
Bertrand, R., O'Connor, P. M., Kerrigan, D., & Pommier, Y. G. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90107-d · Cited by 108
Self-citationBacterial topoisomerase I as a target for discovery of antibacterial compounds
Tse-Dinh, Y.-C. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn936 · Cited by 107
Vaccinia virus DNA topoisomerase: a model eukaryotic type IB enzyme
Shuman, S. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00144-4 · Cited by 93
Lovett, B. D., Strumberg, D., Blair, I. A., Pang, S., Burden, D. A., Megonigal, M. D., Rappaport, E. F., Rebbeck, T. R., Osheroff, N., Pommier, Y. G., et al. (2001) · Biochemistry · doi:10.1021/bi002361x · Cited by 89
Self-citationA poxvirus-like type IB topoisomerase family in bacteria
Krogh, B. O., & Shuman, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032613199 · Cited by 87
The Interaction of Drugs with DNA Gyrase: A Model for the Molecular Basis of Quinolone Action
Heddle, J. G., Barnard, F. M., Wentzell, L. M., & Maxwell, A. (2000) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770008033048 · Cited by 83
Chk2 Molecular Interaction Map and Rationale for Chk2 Inhibitors
Pommier, Y. G., Weinstein, J. N., Aladjem, M. I., & Kohn, K. W. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0743 · Cited by 83
Self-citationLin, C., Ban, Y., Lyu, Y. L., & Liu, L. F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030601 · Cited by 78
Soret, J., Gabut, M., Dupon, C., Kohlhagen, G., Stévenin, J., Pommier, Y., & Tazi, J. (2003) · PubMed · Cited by 77
Self-citationA Journey in the World of DNA Rings and Beyond
Wang, J. C. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.030107.090101 · Cited by 76
Interfacial Inhibitors of Protein-Nucleic Acid Interactions
Pommier, Y. G., & Marchand, C. (2005) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011054222337 · Cited by 74
Self-citationPommier, Y. G., Kerrigan, D., Covey, J. M., Kao-Shan, C. S., & Whang‐Peng, J. (1988) · PubMed · Cited by 71
Self-citationA truncated form of DNA topoisomerase IIβ associates with the mtDNA genome in mammalian mitochondria
Low, R. L., Orton, S., & Friedman, D. B. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03814.x · Cited by 69
Byl, J. A. W., Fortune, J. M., Burden, D. A., et al. (1999) · Biochemistry · doi:10.1021/bi991791o · Cited by 66
Mitochondrial Topoisomerase I Sites in the Regulatory D-Loop Region of Mitochondrial DNA
Zhang, H., & Pommier, Y. G. (2008) · Biochemistry · doi:10.1021/bi800774b · Cited by 63
Self-citationHuman topoisomerase II uses a two-metal-ion mechanism for DNA cleavage
Deweese, J. E., Burgin, A. B., & Osheroff, N. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn466 · Cited by 61
Synthesis and pharmacological evaluation of novel non-lactone analogues of camptothecin
Hautefaye, P., Cimetiere, B., Pierré, A., Léonce, S., Hickman, J. A., Laine, W., Bailly, C., & Lavielle, G. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00534-1 · Cited by 61
Takagi, K., Dexheimer, T. S., Redon, C. E., Sordet, O., Agama, K., Lavielle, G., Pierré, A., Bates, S. E., & Pommier, Y. G. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0441 · Cited by 59
Self-citationDNA Repair Functions That Control Sensitivity to Topoisomerase-Targeting Drugs
Malik, M., & Nitiss, J. L. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.1.82-90.2004 · Cited by 53
Mitochondrial topoisomerases and alternative splicing of the human TOP1mt gene
Zhang, H., Meng, L., & Pommier, Y. G. (2006) · Biochimie · doi:10.1016/j.biochi.2006.11.002 · Cited by 47
Self-citationCinelli, M. A., Cordero, B., Dexheimer, T. S., Pommier, Y. G., & Cushman, M. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.08.066 · Cited by 46
Self-citationUrasaki, Y., Takebayashi, Y., & Pommier, Y. G. (2000) · PubMed · Cited by 43
Self-citation
Cited by
Anand, U., Dey, A., Chandel, A. K. S., Sanyal, R., Mishra, A., Pandey, D. K., De Falco, V., Upadhyay, A., Kandimalla, R., Chaudhary, A., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.02.007 · Cited by 1,834
The DNA damage response and cancer therapy
Lord, C. J., & Ashworth, A. (2012) · Nature · doi:10.1038/nature10760 · Cited by 1,649
Targeting the DNA Damage Response in Cancer
O’Connor, M. J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.040 · Cited by 1,518
Cellular senescence promotes adverse effects of chemotherapy and cancer relapse
Demaria, M., O'Leary, M. N., Chang, J., Shao, L., Liu, S., Alimirah, F., Koenig, K., Le, C., Mitin, N., Deal, A. M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0241 · Cited by 1,338
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
Metadata
- Authors
- Pommier, Y., Leo, E., Zhang, H., & Marchand, C.
- Venue
- Chemistry & Biology
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 17
- Issue
- 5
- Pages
- 421-433
- ISSN
- 1074-5521 (ISSN-L)
- OpenAlex
- W2068577449
- Cited by
- 1,829
- References
- 103
- FWCI
- 29.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.